Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humacyte (HUMA) Current Assets (2024 - 2025)

Humacyte has reported Current Assets over the past 2 years, most recently at $67.8 million for Q4 2025.

  • Quarterly results put Current Assets at $67.8 million for Q4 2025, up 41.66% from a year ago — trailing twelve months through Dec 2025 was $67.8 million (up 41.66% YoY), and the annual figure for FY2025 was $67.8 million, up 41.66%.
  • Current Assets for Q4 2025 was $67.8 million at Humacyte, up from $41.4 million in the prior quarter.
  • Over the last five years, Current Assets for HUMA hit a ceiling of $117.9 million in Q1 2024 and a floor of $23.0 million in Q3 2024.